FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

32570211000036100: Substance foundation reference set (foundation metadata concept)


Status: current, Primitive. Date: 30-Nov 2009. Module: SNOMED Clinical Terms Australian extension

Descriptions:

Id Description Lang Type Status Case? Module
108642371000036113 Substance foundation reference set (foundation metadata concept) en Fully specified name Active Case insensitive SNOMED Clinical Terms Australian extension
108642381000036110 Substance foundation reference set en Synonym Active Case insensitive SNOMED Clinical Terms Australian extension
4351461000168113 <p>Supports the recording of substances in Australian e-health implementations.</p><p>This reference set can be used:<ul><li>Within implementations where use-case specific reference sets for substances are yet to be developed.</li><li>As the basis for developing further use-case specific reference sets for substances, through a process of constraint.</li><li>As a benchmark against which use-case specific reference sets that have been developed by the SNOMED CT-AU user community can be tested to assure that they are logical constraints of content relating to substances.</li></ul></p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive SNOMED Clinical Terms Australian extension


27331 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance foundation reference set Developed by Australian Digital Health Agency true Inferred relationship Some 926724414
Substance foundation reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1675684939
Substance foundation reference set Is a Foundation reference sets true Inferred relationship Some
Substance foundation reference set Is a Attribute value type false Inferred relationship Some
Substance foundation reference set Is a Simple type reference set true Inferred relationship Some

Members
Substance categorised by structure
Substance categorised functionally
3',5'-cyclic-nucleotide phosphodiesterase inhibitor
HMG-CoA reductase inhibitor
4-aminobutyrate - 2-oxoglutarate transaminase inhibitor
4-hydroxyphenylpyruvate dioxygenase inhibitor
5-alpha reductase inhibitor
5-HT3 receptor antagonist
5-lipoxygenase inhibitor
A4beta2 acetylcholine receptor partial agonist
B-Raf inhibitor
C1 esterase inhibitor
C1q esterase inhibitor
Cytomegalovirus terminase complex inhibitor
Hepatitis C virus NS3/4A protease inhibitor
Hepatitis C virus protein NS5A inhibitor
Hepatitis C virus protein NS5B inhibitor
Human immunodeficiency virus entry inhibitor
Human immunodeficiency virus fusion inhibitor
Janus kinase inhibitor
NMDA receptor antagonist
NAD(P)H dehydrogenase (quinone) inhibitor
P2Y12 G-protein-coupled platelet receptor antagonist
RNA polymerase inhibitor
Rho-associated protein kinase inhibitor
Acaricide
Acetylcholine receptor agonist
Acetylcholine receptor antagonist
Acetylcholinesterase inhibitor
Acetylcholinesterase reactivator
Acetylserotonin-O-methyltransferase inhibitor
Activated protein C inhibitor
Adenosine A2 receptor agonist
Adenosine deaminase inhibitor
Adenosine receptor antagonist
Adrenergic neurone blocker
Adrenergic receptor agonist
Substance with adrenergic receptor antagonist mechanism of action
Adrenergic uptake inhibitor
Alcohol dehydrogenase inhibitor
Substance with alcohol structure
Aldehyde dehydrogenase inhibitor
Aldolase
Aldosterone receptor antagonist
Alkaline phosphatase inhibitor
Alpha adrenergic receptor agonist
Alpha adrenergic receptor antagonist
Alpha-1 adrenergic receptor antagonist
Alpha-2 adrenergic receptor agonist
Alpha-2 adrenergic receptor antagonist
Alpha-4 integrin receptor antagonist
Alpha-adrenergic and beta-adrenergic agonist
Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist
Alpha-glucosidase inhibitor
Alpha1 proteinase inhibitor
Amoebicide
Aminoglycoside antibacterial
Aminotransferase inhibitor
Aminotransferase
Androgen receptor agonist
Androgen receptor antagonist action
Androgen synthesis inhibitor
Angiogenesis inhibitor
Angiotensin II receptor antagonist
Angiotensin-converting enzyme inhibitor
Anion exchange resin
Anthelmintic
Antiandrogen
Antibacterial
Antifungal
Antimalarial
Antimycobacterial
Antiprotozoal
Antiretroviral
Antiviral
Arachidonate 5-lipoxygenase inhibitor
Aromatase inhibitor
Aspartic proteinase inhibitor
Substance with azepane structure
Azole antifungal
Substance with benzamide structure
Substance with benzene structure
Benzodiazepine receptor antagonist
Beta adrenergic receptor agonist
Beta blocker
Selective beta-1 adrenoceptor agonist
Beta-1 adrenergic receptor antagonist
Selective beta-2 agonist
Beta-2 adrenergic receptor antagonist
Selective beta-3 agonist
Beta-lactam antibacterial
Substance with beta-lactamase inhibitor mechanism of action
Substance with biopterin structure
Bradykinin B2 inhibitor
Calcineurin inhibitor
Calcitonin gene-related peptide receptor antagonist
Calcium channel blocker
Calcium-sensing receptor activator
Cannabinoid receptor agonist
Carbonic anhydrase inhibitor
Carboxylase

Start Previous Page 243 of 274 Next End


Reference Sets

Reference set descriptor

Back to Start